<DOC>
	<DOCNO>NCT03040206</DOCNO>
	<brief_summary>This study investigate prognostic significance enhance International Prognostic Index ( NCCN-IPI ) post-treatment PET result patient newly diagnose nodal peripheral T-cell lymphoma ( PTCL ) , establish risk stratification model nodal PTCL patient .</brief_summary>
	<brief_title>Risk Stratification Nodal PTCL</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Peripheral</mesh_term>
	<mesh_term>Lymphoma , Large-Cell , Anaplastic</mesh_term>
	<mesh_term>Immunoblastic Lymphadenopathy</mesh_term>
	<criteria>Patients diagnose nodal PTCLs ( PTCL , NOS ; Angioimmunblastic Tcell lymphoma ; anaplastic large cell lymphoma [ ALCL ] , anaplastic lymphoma kinase [ ALK ] negative ) Patients diagnose January 1 , 2004 April 30 , 2016 initially treat curative intent Patients standard 18Ffluorodeoxyglucose ( FDG ) PET PETCT data time diagnosis end primary treatment Patients diagnose extranodal PTCLs , include following ( extranodal NK/Tcell lymphoma , nasal type ; enteropathyassociated Tcell lymphoma ; hepatosplenic Tcell lymphoma ; subcutaneous panniculitislike Tcell lymphoma ; EBVpositive Tcell lymphoproliferative childhood disorder , primary cutaneous lymphoma ) Patients ALCLALK+ Patients 18FFDG PET PETCT data either diagnosis end treatment available review</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>